Drug Database
Back to search

Poland· PL-100105492

Azilect

A rasagiline product containing rasagilinum, registered in Poland by Teva B.V.. The same ATC class is registered in 19 of our 19 countries.

ATC N04BD02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAzilectATCN04BD02REGISTER NO.PL-100105492PACKS LISTED7CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about rasagilinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Rasagiline is registered in 19 of 19 countries.

Countries holding a registration under ATC N04BD02 (rasagiline), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose
Search rasagiline products by name

Rasagiline · ATC N04BD02

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rasagiline costs, country by country.

Normalised to the WHO defined daily dose (1 mg), the median price runs from $1.28 in France to $3.47 in Spain — a ×2.7 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Rasagiline · price per daily dose (1 mg)

USD · FX 28 Sept 2026

  • ES Spain$3.47
  • CH Switzerland$3.02
  • IT Italy$2.36
  • FR France$1.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Rasagilinum
Manufacturer
Teva B.V.
Country
Poland (PL)
ATC code
N04BD02
ATC class
Rasagiline
Defined daily dose
1 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

  • gtin
    05909990016464
  • gtin
    05909990016471
  • gtin
    05909990016488
  • gtin
    05909990016440
  • gtin
    05909990016457
  • gtin
    05909990016495
  • gtin
    05909990016501

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

200 interactions on record for rasagiline.

Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check rasagiline against other medicinesHow interaction checks work

Rasagiline · interactions on record

200 records

  • 28 severe
  • 157 moderate

Most severe, free to view

  • FenfluramineA08AA02severe
  • DexfenfluramineA08AA04severe
  • SibutramineA08AA10severe
  • TiclopidineB01AC05severe

15 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rasagiline in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rasagiline products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Rasagilin +pharma, Rasagilin 1a Pharma
  • Belgium · Rasagiline Eg, Rasagiline Krka
  • Bulgaria · Ралаго, Сагилия
  • Cyprus · Azipron, Rasagiline Krka
  • Czechia · Detreman, Ralago
  • Germany · Rasagea, Rasagilin 1 A Pharma
  • Denmark · Rasagilin Accord, Rasagilin Glenmark
  • Estonia · Ralago, Sagilia
  • Spain · Altina, Neuromiol
  • Finland · Rasabon, Rasagilin
  • France · Rasagiline Accord, Rasagiline Arrow
  • United Kingdom (Northern Ireland) · Azilect, Rasagiline
  • Greece · Asarkin, Ractilen
  • Croatia · Azipron, Ralago
  • Hungary · Ralago, Rasagiline Stada
  • Ireland · Rasagiline Accord, Rasagiline Clonmel
  • Iceland · Azilect, Rasagilin Krka
  • Italy · Aidex, Nalisar
  • Liechtenstein · Azilect, Rasagiline Ratiopharm
  • Lithuania · Ralago, Rasagiline Sandoz
  • Luxembourg · Rasagilin Micro Labs, Rasagiline Eg
  • Latvia · Ralago
  • Malta · Rasagiline Ascend, Sagilia
  • Netherlands · Rasagiline Aurobindo, Rasagiline Bioorganics
  • Norway · Azilect, Rasagilin Accord
  • Portugal · Detreman, Rasagilina Alras Alter
  • Romania · Hiperavia, Sagilia
  • Sweden · Rasagilin Glenmark, Rasagilin Krka
  • Slovenia · Ralago, Razagilin Krka
  • Slovakia · Ralago, Rasagiline Egis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/de2d961a-16c1-4805-889e-7328588ff454
GET /v1/drugs/de2d961a-16c1-4805-889e-7328588ff454?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "1 mg",
  "packaging": "05909990016440 ¦ Rp ¦ EU/1/04/304/001 ¦ 25420\n7 tabl.\n05909990016457 ¦ Rp ¦ EU/1/04/304/002 ¦ 25533\n10 tabl.\n05909990016464 ¦ Rp ¦ EU/1/04/304/003 ¦ 25563\n28 tabl.\n05909990016471 ¦ Rp ¦ EU/1/04/304/004 ¦ 25603\n30 tabl. w blistrze\n05909990016488 ¦ Rp ¦ EU/1/04/304/005 ¦ 25683\n100 tabl.\n05909990016495 ¦ Rp ¦ EU/1/04/304/006 ¦ 25684\n112 tabl.\n05909990016501 ¦ Rp ¦ EU/1/04/304/007 ¦ 25685\n30 tabl. w butelce\nRp ¦ Skasowane ¦ EU/1/04/304/008 ¦ 122037\n10 tabl. (10 x 1)\nRp ¦ Skasowane ¦ EU/1/04/304/009 ¦ 122038\n30 tabl. (30 x 1)\nRp ¦ Skasowane ¦ EU/1/04/304/010 ¦ 122039\n100 tabl. (100 x 1)",
  "substance": "Rasagilinum 1 mg",
  "common_name": "Rasagilinum",
  "pl_product_id": "100105492",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about rasagiline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console